127 related articles for article (PubMed ID: 6490167)
1. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
Infection; 1984; 12(4):248-50. PubMed ID: 6490167
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC
Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
[TBL] [Abstract][Full Text] [Related]
4. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
5. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
Loeschke K; Abb J; Farack UM; Wiebecke B
Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
[TBL] [Abstract][Full Text] [Related]
6. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
[TBL] [Abstract][Full Text] [Related]
7. Isoprinosine in the treatment of chronic active hepatitis type B.
Cianciara J; Laskus T; Gabinska E; Loch T
Scand J Infect Dis; 1990; 22(6):645-8. PubMed ID: 1704640
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
Watanabe S; Saito S; Yoshikawa A; Shibayama T; Kamimura T; Suzuki S; Ischida F
Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
10. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
Scullard GH; Andres LL; Greenberg HB; Smith JL; Sawhney VK; Neal EA; Mahal AS; Popper H; Merigan TC; Robinson WS; Gregory PB
Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
[No Abstract] [Full Text] [Related]
11. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
Guerre J; Gaudric M; Couturier D; Levy C
Presse Med; 1983 Mar; 12(12):743-6. PubMed ID: 6220311
[TBL] [Abstract][Full Text] [Related]
12. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
Yokosuka O; Omata M; Imazeki F; Hirota K; Mori J; Uchiumi K; Ito Y; Okuda K
Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV
J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
[TBL] [Abstract][Full Text] [Related]
14. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC
Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
[TBL] [Abstract][Full Text] [Related]
15. Effects of adenine arabinoside on cellular immune responses in patients with chronic hepatitis B.
Hyodo I; Yamada G; Manabe K; Okushin H; Mizuno M; Nagashima H
Gastroenterol Jpn; 1986 Jun; 21(3):220-7. PubMed ID: 3732754
[TBL] [Abstract][Full Text] [Related]
16. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
Hoofnagle JH
J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
[TBL] [Abstract][Full Text] [Related]
17. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
[TBL] [Abstract][Full Text] [Related]
18. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
Chadwick RG; Bassendine MF; Crawford EM; Thomas HC; Sherlock S
Br Med J; 1978 Aug; 2(6136):531-3. PubMed ID: 698557
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment.
Scullard GH; Greenberg HB; Smith JL; Gregory PB; Merigan TC; Robinson WS
Hepatology; 1982; 2(1):39-49. PubMed ID: 6172352
[TBL] [Abstract][Full Text] [Related]
20. [Effects of arabinoside adenine in chronic HBsAg-positive hepatitis].
Pofi E; Aragona G; Caserta G; Rosa A
Clin Ter; 1983 Oct; 107(2):147-50. PubMed ID: 6661878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
